Inventor · disambiguated record
Rachel C. Nering
Also filed as: NERING RACHEL C
2 granted patents·3 pending applications·5 citations·filing 2015–2017
52Inventor score
Files withMERRIMACK PHARMACEUTICALS INC5
Top patents by PatentIndex Score
5 records- 0184US9688761B2Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapiesMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·4 cites·24 claims
- 0274US10273304B2Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapiesMERRIMACK PHARMACEUTICALS INC·Filed 2017·Granted Apr 30, 2019·1 cites·36 claims
- 0355US2017210810A1Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0431US2016303232A1Combination treatments with seribantumabMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0530US2016311908A1Methods of treating patients having mutations in the extracellular domain of epidermal growth factor receptor (egfr) with a combination of three fully human monoclonal anti-egfr antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rachel C. Nering files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →